Limitations, agreements, and source contact

ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma · Source last updated 2021-06-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

yubin.kang@duke.edu

organization

Duke University Medical Center, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy

phone

(919) 668-2331

title

Yubin Kang, M.D., Principal Investigator

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice